- The Safe Use of the COVID -19 Vaccine: Focusing on Allergic Reactions
-
Kim SR, Lee JHn
- KMID: 2534649
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):55-61.
- doi: 10.56142/2021.13.2.55
As treatment options for the COVID-19 pandemic are limited, the most effective strategy so far is to obtain herd immunity through vaccination; however, the fear of adverse reactions following immunization... -
- CITED
-
- Close
- SHARE
-
- Close
- Paradigm Shift of Pharmacovigilance: 10 Years’ Experience of Active Surveillance by One Regional Pharmacovigilance Center
-
Lee MG
- KMID: 2534667
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):87-90.
- doi: 10.56142/2021.13.2.87
21st century pharmacovigilance is not merely about the identification of adverse events but also includes systemic preand post-market surveillance and a complete understanding of the risks associated with certain drugs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Postmarket Surveillance Strategies of Implantable Medical Devices in the United States, European Union, and South Korea
-
Cho Yo, Lee JYe, Shim DaYo, Park SJ, Rhee HE, Sung HG, Kim HJ, Choi NK, Song HJ, K im JA, Park Sm, Shin JY
- KMID: 2534648
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):45-54.
- doi: 10.56142/2021.13.2.45
The biomedical industry is making rapid progresses like never before, and the number of adverse events caused by implantable medical devices is also increasing. As such, there is an ever-growing... -
- CITED
-
- Close
- SHARE
-
- Close
- Adverse Reactions after the Second Dose of ChAdOx1 COVID-19 Vaccine in H ealthcare Workers
-
Kim HJ, Kim HH, Park S, Yeom HJ, Jang JY, Park Gy, Kang HR, Kang DY
- KMID: 2534650
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):62-69.
- doi: 10.56142/2021.13.2.62
Objective: The Seoul National University Hospital Drug Safety Monitoring Center performed a prospective survey regarding adverse reactions after the second dose of the adenovirus-vectored vaccine (ChAdOx1 nCoV-19) in healthcare workers.... -
- CITED
-
- Close
- SHARE
-
- Close
- Surveillance of Adverse Drug Reactions to First-line Antitu berculosis Drugs Using Common Data Model
-
Byeon Sj, Park HA, Kang DY, Choi IY, Choi JH
- KMID: 2534666
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):78-86.
- doi: 10.56142/2021.13.2.78
Objective: Tuberculosis (TB) remains a major health problem with high rates of mortality in Korea. Adverse drug reactions (ADRs) to anti-TB drugs negatively affect drug compliance, lead to poor prognosis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Labeling Status of Culprit Drugs Inducing Severe Cutaneous Adverse Reactions
-
Yeom HJ, Kim HHw, Kim HJ, Park S, Jang JY, Park GY, Kang DY, Kang HR
- KMID: 2534651
- J Pharmacoepidemiol Risk Manage.
- 2021 Sep;13(2):70-77.
- doi: 10.56142/2021.13.2.70
Objective: The labeling status of culprit drugs of Severe Cutaneous Adverse Reactions (SCAR) was evaluated by comparing the labeling status of the US Food and Drug Administration (FDA) to the... -
- CITED
-
- Close
- SHARE
-
- Close
